The Neuroscience of Psychedelics: Therapeutic Mechanisms and Implications for Understanding Consciousness - Matthew Banks, PhD
Intended Audience
The target audiences for this activity are clinical anesthesia providers in the Department of Anesthesiology, which includes both faculty physicians (MD, DO) as well as residents or fellows in training, and RNs. Other specialties who would benefit from attending include PA, pharmacists, pharmacy technicians, students, and clinical anesthetists.
Learning Objectives
As a result of participation in this educational activity, members of the healthcare team will:
- Outline the evidence that psychedelics such as psilocybin ameliorate symptoms of depression and anxiety in patients.
- Identify the inherent limitations of randomized clinical trials focused on the therapeutic effects of psychedelics.
- Explain the role of neural plasticity in the mechanisms of long-term behavioral effects of psychedelics.
- Explain the role of changes in brain entropy in the mechanisms of long-term behavioral effects of psychedelics.
FACULTY DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing educational activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Matthew Banks, PhD | Presenter | VCENNA, Inc- Independent Contractor | No |
Planning Committee Disclosures
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Kristin Bevil | RSS Chair | No relevant financial relationships with ineligible companies to disclose. | No |
Kimberly Rogan | RSS Coordinator | No relevant financial relationships with ineligible companies to disclose. | No |
Joel Johnson | Planner | No relevant financial relationships with ineligible companies to disclose. | |
Kelly McQueen | Planner | No relevant financial relationships with ineligible companies to disclose. | |
Kristopher Schroeder | Planner | No relevant financial relationships with ineligible companies to disclose. | No |
Disclosures for Planning Committee - January 1, 2023 – February 28, 2023
Disclosures for Planning Committee
Accreditation Statement
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the material.
American Board of Anesthesiology (ABA)
This enduring material contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements. Participant completion information will be shared with the ABA through PARS. By recording your attendance at this event, you are giving UW-ICEP permission to share this information with ABA.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1.00 hour.
Available Credit
- 1.00 MOCA 2.0®: ABA Lifelong Learning Points (Part II)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to help@icep.wisc.edu
ACCESSIBILITY
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu
Required Hardware/software
Computer, tablet, or other mobile device with sound.
Free, current version of Edge, Firefox, Safari, or Chrome. Some older browsers and Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.